In 2023, state and local governments received $15 billion from opioid crisis settlements, marking a crucial turn in combating addiction. This article explores the nuances of these settlements, covering shifting dynamics and challenges. 1. Settlement Landscape: Major companies, including Johnson & Johnson and Teva Pharmaceutical, reached nationwide agreements, but hurdles like Purdue Pharma’s $60 billion… Continue reading Decoding Opioid Crisis Settlements: Funds, Challenges, and Outcomes
Day: January 10, 2024
Integrating Mental Health into Medication Support Services
In an effort to enhance patient adherence and seek early intervention for mental health conditions, Medication Support Services (MSS) now extends its support to cover antidepressant medications. Despite patients with severe and persistent mental health issues often being prescribed new medications, none of the 16 areas covered by MSS address mental health conditions. Encouragingly, in… Continue reading Integrating Mental Health into Medication Support Services
Decoding GLP-1 Receptor Agonists: Navigating Diabetes, Pancreatic Cancer, and a Surprising Ally Against Colorectal Cancer
GLP-1RAs and Pancreatic Cancer: Reassuring Findings A recent cohort study, led by Dr. Rachel Dankner and her team, investigates the association between GLP-1RAs and pancreatic cancer in type 2 diabetes patients. Surprisingly, after several years of use, no safety signal for pancreatic cancer was observed when compared to baseline insulin users. The meticulous analysis considered… Continue reading Decoding GLP-1 Receptor Agonists: Navigating Diabetes, Pancreatic Cancer, and a Surprising Ally Against Colorectal Cancer
English 
Spanish